2014
DOI: 10.1515/pac-2014-0504
|View full text |Cite
|
Sign up to set email alerts
|

100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs

Abstract: Citation: Barry NPE and Sadler PJ (2014)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
35
0
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 72 publications
(40 citation statements)
references
References 85 publications
0
35
0
2
Order By: Relevance
“…[1] Indeed, the replacement of a coordinated water molecule by an entering ligand represents a key step in the formation of metal complexes in aqueous solutions [2] and in many redox processes. [3] The mean residence times of coordinated water molecules in aquated complexes spread over 20 orders of magnitude from ca.…”
Section: Introductionmentioning
confidence: 99%
“…[1] Indeed, the replacement of a coordinated water molecule by an entering ligand represents a key step in the formation of metal complexes in aqueous solutions [2] and in many redox processes. [3] The mean residence times of coordinated water molecules in aquated complexes spread over 20 orders of magnitude from ca.…”
Section: Introductionmentioning
confidence: 99%
“…Such compounds have found tremendous applications in catalysis or biosensing but, as surprising as it can be for certain readers of this article, also in medicine. [2][3][4][5][6][7] At this stage of the review, it is important to highlight that the famous platinum(II) anticancer drugs cisplatin, oxaliplatin and carboplatin, the antiarthritic gold(I) auranofin or the MRI agents based on gadolinium(III) are not organometallic complexes since they do not have a metalcarbon bond -they are defined as coordination complexes.…”
Section: Introductionmentioning
confidence: 99%
“…One of them is its dose‐limiting toxic effects such as nausea, deafness, vomiting, loss of sensation in hands, and kidney damage, and the other one is its inactivity and/or inability against some tumor types namely leukemia, renal, gastrointestinal cancers and non‐small cell lung cancers. These limitations explain the focused attention on the search for new platinum based drugs active towards cisplatin refractory/resistant tumors .…”
Section: Introductionmentioning
confidence: 99%